PRRT2 and melanoma: Solid tumours such as melanoma may also be poorly perfused and hypoxic, so that low penetration of midostaurin (tissue/plasma ratio median 0.29) into solid tumours may also account for inconsistent intra-tumoral PKC inhibition.